Request Customization - Saudi Arabia Digital Therapeutics Market Size & Outlook by 2032

Saudi Arabia Digital Therapeutics Market Research Report: Forecast (2026-2032)

Saudi Arabia Digital Therapeutics Market - By Type of Solution (Software Solution, Gaming Solution, Combination Solution), By Application (Preventive, Pre-Diabetes, Obesity, Smoking Cessation, Other... ... ing Cessation, Others (Hypertension, Sleep Hygiene, etc.), Treatment/Care, Cardiovascular Diseases (CVDs), Central Nervous System Diseases, Diabetes, Musculoskeletal Diseases, Others (Respiratory Diseases, Drug Substance Abuse, etc.), By Purpose of Solution (Medication Replacement Solutions, Medication Augmentation Solutions), By Business Model (Business-to-Consumer (B2C), Business-to-Business (B2B), By End User (Healthcare Providers, Insurance Companies, Individuals, Employers, Others), and others Read more

Healthcare
Dec 2025
Pages 135
Report Format: PDF, Excel, PPT

Saudi Arabia Digital Therapeutics Market Size: Forecast (2026- 2032)

The Saudi Arabia Digital Therapeutics Market size is valued at around USD 34 million in 2025 and is projected to reach USD 62 million by 2032. Along with this, the market is estimated to grow at a CAGR of around 8.96% during the forecast period, i.e., 2026-32.

The Saudi Arabia Digital Therapeutics Market is expanding rapidly, driven by rising chronic disease prevalence and rapid digital-health modernization. National health statistics show that nearly one-quarter of adults are obese, while 45.1% are overweight, creating a sizable population requiring continuous metabolic, behavioral, and medication support.

This burden is compounded by complex comorbidities, as a 2023 retrospective study found that among individuals with type 2 diabetes, 67.7% also had hypertension, 69.0% had dyslipidemia, 18.6% were living with ASCVD, 8.7% had chronic kidney disease, and 5.1% had heart failure. These patterns highlight an urgent need for scalable, software-enabled disease-management solutions.

AI-powered personalized health coaching is becoming central to that response. Platforms such as Sehhaty increasingly integrate predictive-risk tools and AI-guided lifestyle pathways, enabling more precise preventive care. At the same time, hospitals and insurers are accelerating the shift toward home-based rehabilitation and continuous remote monitoring, supporting digital physiotherapy, cardiac rehabilitation, and mental-wellness programs. This migration toward virtual, AI-enabled care underscores the Kingdom’s broader move toward digital therapeutics as a standard of care.

The National Health Intelligence Initiative (NHI), launched in late 2025, is designed to unify Saudi Arabia’s health datasets and deploy population-scale predictive analytics as an essential foundation for advanced DTx models. Meanwhile, Seha Virtual Hospital continues expanding its network, improving access to AI-supported diagnostics and remote chronic-disease management, particularly in underserved regions.

Long-term investment reinforces this trajectory. The Ministry of Health has allocated over USD 33 billion to healthcare transformation, including AI integration, telemedicine infrastructure, and nationwide EHR interoperability. These developments will deepen preventive care, streamline chronic-disease management, and embed DTx solutions across clinical pathways, positioning digital therapeutics as a core pillar of Saudi Arabia’s future healthcare system.

Overall, the convergence of chronic-disease burdens, nationwide AI integration, expanding virtual-care infrastructure, and future health investments ensures strong forward momentum, positioning digital therapeutics for sustained, accelerated growth across Saudi Arabia’s healthcare ecosystem in the coming years.

Saudi Arabia Digital Therapeutics Market Recent Developments:

February 2025: Aster DM Healthcare launched its myAster digital-health app in Saudi Arabia, introducing teleconsultations, e-pharmacy services, chronic-care tools, and AI-driven Arabic voice assistance developed with Google Cloud. The rollout marks a major step in Aster’s USD 250 million plan to expand integrated digital and physical healthcare services across the Kingdom.
October 2025: Saudi Arabia’s Ministry of Health designated Sehhaty as the unified national e-health platform and, in collaboration with Lean Business Services and Google Cloud, introduced an AI-driven Smart Health Coach. The new feature delivers personalized guidance, health monitoring, and preventive-care support, strengthening the Kingdom’s digital-therapeutics ecosystem.

Saudi Arabia Digital Therapeutics Market Scope:

Category	Segments
By Type of Solution	Software Solution, Gaming Solution, Combination Solution),
By Application	Preventive, Pre-Diabetes, Obesity, Smoking Cessation, Others (Hypertension, Sleep Hygiene, etc.), Treatment/Care, Cardiovascular Diseases (CVDs), Central Nervous System Diseases, Diabetes, Musculoskeletal Diseases, Others (Respiratory Diseases, Drug Substance Abuse, etc.),
By Purpose of Solution	Medication Replacement Solutions, Medication Augmentation Solutions), By Business Model (Business-to-Consumer (B2C), Business-to-Business (B2B),
By End User	Healthcare Providers, Insurance Companies, Individuals, Employers, Others), and others

Saudi Arabia Digital Therapeutics Market Drivers:

High Prevalence of Chronic Disease

The high prevalence of chronic diseases in Saudi Arabia, particularly obesity, diabetes, and cardiovascular diseases, continues to accelerate demand for digital therapeutics that enable ongoing monitoring, early intervention, and scalable long-term disease management. A national evidence review shows obesity rates ranging from 20–39%, with 60.7% of obese adults living with type 2 diabetes and 67.6% with hypertension, underscoring the scale of multi-morbidity and the need for continuous, technology-enabled care.

Cardiovascular disease (CVD) trends further underscore the urgency for scalable digital health solutions. A 2024 population-based analysis reports that 1.6% of adults currently live with CVD. Still, prevalence escalates to 11% among individuals aged 65 and above, highlighting the rising burden of long-term disease management as the population ages.

Alongside health implications, chronic diseases pose an immense economic challenge as obesity and its related illnesses generate an estimated USD 116.85 billion in annual economic losses, with USD 109.7 billion directly absorbed by the healthcare system, placing sustained pressure on national resources.

Beyond 2025, national strategies targeting obesity reduction, preventive care, and digital health integration are expected to expand, supporting digital therapeutics for lifestyle modification, remote monitoring, and metabolic-risk management. As chronic-disease rates rise, DTx adoption will accelerate, offering scalable, cost-effective care for a growing high-risk population.

Overall, the growing chronic-disease burden, rising healthcare costs, and government-backed digital-health expansion will significantly strengthen the long-term demand for digital therapeutics across Saudi Arabia.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Saudi Arabia Digital Therapeutics Market Policies, Regulations, and Product Standards
Saudi Arabia Digital Therapeutics Market Supply Chain Analysis
Saudi Arabia Digital Therapeutics Market Trends & Developments
Saudi Arabia Digital Therapeutics Market Dynamics
1. Growth Drivers
2. Challenges
Saudi Arabia Digital Therapeutics Market Hotspot & Opportunities
Saudi Arabia Digital Therapeutics Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Type of Solution – Market Size & Forecast 2022-2032, USD Million
    1. Software Solution
    2. Gaming Solution
    3. Combination Solution
  2. By Application – Market Size & Forecast 2022-2032, USD Million
    1. Preventive
      1. Pre-Diabetes
      2. Obesity
      3. Smoking Cessation
      4. Others (Hypertension, Sleep Hygiene, etc.)
    2. Treatment/Care
      1. Cardiovascular Diseases (CVDs)
      2. Central Nervous System Diseases
      3. Diabetes
      4. Musculoskeletal Diseases
      5. Others (Respiratory Diseases, Drug Substance Abuse, etc.)
  3. By Purpose of Solution – Market Size & Forecast 2022-2032, USD Million
    1. Medication Replacement Solutions
    2. Medication Augmentation Solutions
  4. By Business Model – Market Size & Forecast 2022-2032, USD Million
    1. Business-to-Consumer (B2C)
    2. Business-to-Business (B2B)
  5. By End User– Market Size & Forecast 2022-2032, USD Million
    1. Healthcare Providers
    2. Insurance Companies
    3. Individuals
    4. Employers
    5. Others
3. By Region
  1. Riyadh
  2. Jeddah
  3. Damam
  4. Mecca & Madinah
  5. Others
4. By Company
  1. Company Revenue Shares
  2. Competitor Characteristics
Saudi Arabia Software Solution Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
2. Market Share & Outlook
  1. By Application – Market Size & Forecast 2022-2032, USD Million
  2. By Purpose of Solution – Market Size & Forecast 2022-2032, USD Million
  3. By Business Model – Market Size & Forecast 2022-2032, USD Million
  4. By End User– Market Size & Forecast 2022-2032, USD Million
  5. By Region
Saudi Arabia Gaming Solution Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
2. Market Share & Outlook
  1. By Application – Market Size & Forecast 2022-2032, USD Million
  2. By Purpose of Solution – Market Size & Forecast 2022-2032, USD Million
  3. By Business Model – Market Size & Forecast 2022-2032, USD Million
  4. By End User– Market Size & Forecast 2022-2032, USD Million & Million Units
  5. By Region
Saudi Arabia Combination Solution Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
  2. By Volume (Million Units)
2. Market Share & Outlook
  1. By Application – Market Size & Forecast 2022-2032, USD Million & Million Units
  2. By Purpose of Solution – Market Size & Forecast 2022-2032, USD Million & Million Units
  3. By Business Model – Market Size & Forecast 2022-2032, USD Million & Million Units
  4. By End User– Market Size & Forecast 2022-2032, USD Million & Million Units
  5. By Region
Saudi Arabia Digital Therapeutics Market Key Strategic Imperatives for Success & Growth
Competition Outlook
1. Company Profiles
  1. Cura
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Alma Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Omada Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Alphaiota
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Clinicy
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Twill Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Name *

Email *

Country *